Annual report
6029.TEDINET S100VI0R
Period2024-01-01 → 2024-12-31
Filed2025-03-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100VK7R (2025-04-04).
Key figures · 138
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥4.7bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.2bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥6m | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥51m | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥987,000 | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥62m | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥15m | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥225m | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥396m | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥21m | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥73m | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥37m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥54m | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2m | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥351m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥441m | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥37m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥54m | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥4.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥4.7bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.6bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.3bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.7bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.4bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-12-31d | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.7bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥201m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥218m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥133m | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥209m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥272m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥31m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥154m | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥564m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥188m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥260m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥300m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥315m | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥896m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥266m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-3.59 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.43 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.22 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.76 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.87 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥139.83 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥142.45 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥133.37 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥147.69 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥154 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 34.9% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.1% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.7% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 3.9% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 0.2% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 142 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 156 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 158 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 165 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 112 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥1.7bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥1.9bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥1.9bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥28m | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥9m | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥33m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥79m | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥31m | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥165m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥397m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥34m | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥90m | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥30m | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥85m | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | −¥157m | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥298m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥579m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.1bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥3.4bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥3.4bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥2.1bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥766m | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥889m | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥2.91 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.57 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.03 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-31.24 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-65.52 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥3.5 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥129.17 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥125.12 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥112.21 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥127.34 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥142.64 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 42.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.5% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.1% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.3% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,287,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,167,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,807,000 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,767,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,889,100 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 65 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 74 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 83 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 89 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 88 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 49
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | ¥2m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥78m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥147m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | employees | at 2024-12-31 | 127 pure |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.5bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.4bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment assets | at 2024-12-31 | ¥2.0bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥40m |
| Toy Sales Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥8m |
| Toy Sales Businessreportable segment | employees | at 2024-12-31 | 15 pure |
| Toy Sales Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥1.8bn |
| Toy Sales Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥1.8bn |
| Toy Sales Businessreportable segment | segment assets | at 2024-12-31 | ¥1.0bn |
| Toy Sales Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥36m |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥78m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥154m |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥4.2bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥4.2bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| —segment total | segment assets | at 2024-12-31 | ¥3.1bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥3m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥80m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-12-31 | −¥80m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥7m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥82m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥134m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥2.8bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥2.7bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥80m |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment assets | at 2023-12-31 | ¥2.3bn |
| Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥92m |
| Toy Sales Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥42m |
| Toy Sales Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥6m |
| Toy Sales Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥1.8bn |
| Toy Sales Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥1.8bn |
| Toy Sales Businessreportable segment | segment assets | at 2023-12-31 | ¥1.2bn |
| Toy Sales Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥34m |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥124m |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥140m |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥4.6bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥4.5bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥80m |
| —segment total | segment assets | at 2023-12-31 | ¥3.5bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥58m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,338
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 9 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 9 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 6 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 5 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.855 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.809 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.525 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.533 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.382 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.074 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.211 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.181 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.515 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.825 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | 127 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | 38 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E30998-000ToySalesBusinessReportableSegmentMember | 15 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E30998-000ToySalesBusinessReportableSegmentMember | 97 | |
| Number of employees | CurrentYearInstant | 142 | |
| Average number of temporary workers | CurrentYearInstant | 135 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 65 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 5 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 40.1 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8.5 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4754000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 78495000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | 78495000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10287000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10287000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10287000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10287000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 8 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 19 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 54 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 96 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 12460 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 12657 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1982 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 9230 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 31603 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 1004 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 289 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 58718 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 102826 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 4400 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |